Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1193 of 1,261
  1. US 6468524

    AAV4 vector and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  2. US 6469037

    Prophylactic or therapeutic drug for renal diseases

    Takeda Chemical Industries Ltd. Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  3. US 6470220

    Diagnosis and treatment of cancers using in vivo magnetic domains

    The Regents of the University of California Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  4. US 6469166

    Thiophenopyrimidines

    Neurocrine Biosciences, Inc. Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  5. US 6469049

    Method of treating, preventing or inhibiting central nervous system injuries and diseases

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  6. US 6468959

    Peroral dosage form for peptide containing medicaments, in particular insulin

    ALFATEC-Pharm GmbH Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  7. US 6468802

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  8. US 6468537

    Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus

    The Board of Trustees of Northwestern University Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  9. US 6469027

    N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  10. US 6469184

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  11. US 6468983

    RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 22, 2002 Β· Expires Oct 17, 2022

    expired
  12. RU 2191009

    METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RARalpha

    ALLERGEN SEHJLZ INK [US] Β· Granted Oct 20, 2002 Β· Expires Oct 15, 2022

    expired
  13. JP 2002302442

    NEW COMPOSITION

    BEECHAM GROUP PLC Β· Granted Oct 18, 2002 Β· Expires Oct 13, 2022

    expired
  14. US 6465001

    Treating medical conditions by polymerizing macromers to form polymeric materials

    The Board of Regents of the University of Texas System Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  15. US 6465468

    Hydroxamic and carboxylic acid derivatives

    Darwin Discovery Limited Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  16. US 6465627

    DAX-1 protein, methods for production and use thereof

    The Regents of the University of California Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  17. US 6465614

    High-affinity response-selective C-terminal analogs of C5a anaphylatoxin

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  18. US 6465612

    Synthetic peptides, conjugation reagents and methods

    The Regents of the University of California Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  19. US 6465496

    Torsemide polymorphs

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 15, 2002 Β· Expires Oct 10, 2022

    expired
  20. US 6462058

    Benzimidazole compound crystal

    Takeda Chemical Industries Ltd. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  21. US 6461640

    Local delivery of fibrinolysis enhancing agents

    The Board of Regents of the University of Texas System Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  22. US 6461806

    Methods for measuring cellular proliferation and destruction rates in vitro and in vivo

    The Regents of the University of California Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  23. US 6461613

    Methods and compositions for the selective regulation of chorionic prostanoids

    The Board of Regents of the University of Texas System Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired
  24. US 6462192

    Processes for large scale production of tetrapyrroles

    Miravant Pharmaceuticals, Inc. Β· Granted Oct 8, 2002 Β· Expires Oct 3, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.